We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
+7.27%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$8.87B
AUM Growth
+$1.06B
Cap. Flow
+$639M
Cap. Flow %
7.2%
Top 10 Hldgs %
4.17%
Holding
3,246
New
442
Increased
1,245
Reduced
1,198
Closed
351

Top Buys

Rank Stock Value
1
OKTA icon
Okta
OKTA
+$37.2M
2
LIN icon
Linde
LIN
+$31.4M
3
TTWO icon
Take-Two Interactive
TTWO
+$30M
4
FISV
Fiserv Inc
FISV
+$27.4M
5
WMT icon
Walmart Inc
WMT
+$25.5M

Top Sells

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$46.1M
2
PYPL icon
PayPal
PYPL
+$31.4M
3
AAPL icon
Apple
AAPL
+$31.3M
4
TMO icon
Thermo Fisher Scientific
TMO
+$28M
5
MRK icon
Merck
MRK
+$27.2M

Sector Composition

Rank Sector Weight
1 Technology 18.34%
2 Consumer Discretionary 15.85%
3 Healthcare 13.89%
4 Industrials 12.4%
5 Financials 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ISEE
2701
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$115K ﹤0.01%
+18,197
New +$117K
GOSS icon
2702
Gossamer Bio
GOSS
$87M
$114K ﹤0.01%
14,096
-28,958
-67% -$251K
MFA
2703
MFA Financial
MFA
$933M
$114K ﹤0.01%
6,201
-11,218
-64% -$198K
BOOM icon
2704
DMC Global
BOOM
$157M
$113K ﹤0.01%
2,005
-2,371
-54% -$130K
PAVM icon
2705
PAVmed
PAVM
$33.9M
$113K ﹤0.01%
39
+6
+18% +$14.2K
SPOK icon
2706
Spok Holdings
SPOK
$241M
$113K ﹤0.01%
+11,706
New +$125K
HBIO icon
2707
Harvard Bioscience
HBIO
$29.2M
$111K ﹤0.01%
+1,328
New +$93.9K
UUUU icon
2708
Energy Fuels
UUUU
$3.53B
$110K ﹤0.01%
18,194
-18,137
-50% -$111K
AXGN icon
2709
Axogen
AXGN
$2.5B
$109K ﹤0.01%
5,058
-2,143
-30% -$43.3K
TGB
2710
Trekor Metals
TGB
$3.05B
$109K ﹤0.01%
51,962
-31,737
-38% -$68.2K
USFD icon
2711
US Foods
USFD
$24B
$109K ﹤0.01%
2,839
-56,819
-95% -$2.2M
CALC icon
2712
CalciMedica
CALC
$10.9M
$106K ﹤0.01%
1,395
-2,949
-68% -$193K
PRU icon
2713
Prudential Financial
PRU
$41.8B
$101K ﹤0.01%
988
-69,920
-99% -$7.14M
ADMA icon
2714
ADMA Biologics
ADMA
$2.22B
$100K ﹤0.01%
62,484
+19,184
+44% +$33.8K
TREC
2715
DELISTED
Trecora Resources
TREC
$97K ﹤0.01%
+11,652
New +$93.7K
ONCT
2716
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$96K ﹤0.01%
1,015
-926
-48% -$110K
CFMS
2717
DELISTED
Conformis, Inc. Common Stock
CFMS
$95K ﹤0.01%
+3,320
New +$78.4K
LYEL icon
2718
Lyell Immunopharma
LYEL
$360M
$94K ﹤0.01%
+290
New +$95.1K
NGD
2719
DELISTED
New Gold Inc
NGD
$93K ﹤0.01%
51,654
+17,926
+53% +$33.8K
TCRT icon
2720
Alaunos Therapeutics
TCRT
$4.86M
$92K ﹤0.01%
232
-91
-28% -$42.5K
HLX icon
2721
Helix Energy Solutions
HLX
$1.41B
$91K ﹤0.01%
16,014
-7,030
-31% -$37K
WVE icon
2722
Wave Life Sciences
WVE
$1.2B
$90K ﹤0.01%
13,550
-61,867
-82% -$404K
JG
2723
Aurora Mobile
JG
$29.8M
$89K ﹤0.01%
+1,370
New +$91.1K
LMNX
2724
DELISTED
Luminex Corp
LMNX
$88K ﹤0.01%
2,403
-114
-5% -$4.14K
VEON icon
2725
VEON
VEON
$3.95B
$87K ﹤0.01%
1,912
-976
-34% -$43.1K
107 108
109
110 111

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, Cubist Systematic Strategies held 3,246 positions worth $8.87B, up 14% from $7.81B the previous quarter. Its ten largest holdings account for 4.2% of the portfolio.

Cubist Systematic Strategies deployed $639M of net new capital in Q2 2021, opening 442 new positions and adding to 1,245 existing holdings. Its largest new stake was American Tower: 39,022 shares worth $10.5M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Aptiv, an estimated $46.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2021 buy was American Tower: 39,022 shares worth $10.5M.
  • Cubist Systematic Strategies added most to Okta in Q2 2021, an estimated $37.2M increase.
  • Cubist Systematic Strategies's biggest Q2 2021 reduction was Aptiv, cutting an estimated $46.1M.
  • Cubist Systematic Strategies fully exited Toro Company in Q2 2021, selling an estimated $7.31M.
  • Cubist Systematic Strategies's ten largest holdings make up 4.2% of its $8.87B portfolio in Q2 2021.
  • Cubist Systematic Strategies opened 442 new positions and closed 351 in Q2 2021.
  • Cubist Systematic Strategies's portfolio value rose 14% quarter-over-quarter to $8.87B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.